News ArchivesRead News
Eye implants offer Parkinson’s hope
Thursday December 15, 2005
Wai Lang Chu
12/13/05(Archives of Neurology) - A new therapy for Parkinson’s disease involving brain implants has been developed by US scientists, who believe this new treatment is a viable alternative to drugs currently used to treat this chronic irreversible brain condition.
Levodopa is currently the most common drug treatment for the brain condition but the pills can leave people susceptible to involuntary movements such as twitches. It is normally prescribed a few years after diagnosis as the symptoms get worse.
In addition, disease progression and long-term oral treatment with levodopa may lead to the development of motor fluctuations and dyskinesias
This new approach involved taking levadopa producing eye cells taken from a dead donor and implanting the directly into the brains of six Parkinsons patients. The researchers reported no serious side effects.
Eye cells that form retinal pigment epithelial tissue produce levodopa and can be isolated from human eye tissue and implanted in the brain. Research on animals has shown that the cell implants can help treat the symptoms safely.
The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinsons, said researcher Natividad Stover of the University of Alabama.
One year later, the patients scored 48 per cent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the report.
"The implants were well tolerated," the report said. "Improvement was also observed in activities of daily living (and) quality of life."
The study is additional proof that the technique could work on humans and paves the way for a larger, more thorough study.
Indeed, Stover added that a randomised, double-blind, placebo-controlled study was now in the pipeline to test the treatment further.
For most patients, the levodopa pills lose their effectiveness over five years or less, and larger and larger doses are needed to keep at bay the involuntary movements and shaking symptomatic of the disease.
Some scientists have viewed implanting foetal stem cells into the brains of Parkinsons patients as a promising avenue to restoring dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.
Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy
Recent NewsAug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement
Jul 19 - What Young-onset Parkinson’s Can Look Like
Jul 7 - Parkinson’s Patients Have a Higher Risk of Developing Melanoma — and Vice Versa, Study Finds
Jun 27 - The rogue protein behind Parkinson’s disease may also protect your gut
Jun 26 - Do Statins Increase Risk of Parkinson’s Disease? Some Researchers Think So
Jun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 20 - Gym offers classes in noncontact boxing for Parkinson’s patients
Jun 19 - Human Limitations Could Prevent Us From Advancing in Science. AI Could Help.
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease